Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. März 2015 07:00 ET | Quelle: Foamix, Ltd.

Foamix Reports Financial Results for the Year Ended December 31, 2014

REHOVOT, Israel, March 18, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused on developing and...
10. März 2015 08:00 ET | Quelle: Foamix, Ltd.

Foamix Pharmaceuticals Fourth Quarter 2014 Conference Call & Webcast Scheduled for Wednesday, March 18

REHOVOT, Israel and BRIDGEWATER, N.J., March 10, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...
04. März 2015 08:00 ET | Quelle: Foamix, Ltd.

Foamix to Present Corporate Overview at the 27th Annual ROTH Conference

REHOVOT, Israel and BRIDGEWATER, N.J., March 4, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...
03. März 2015 08:00 ET | Quelle: Foamix, Ltd.

Foamix to Present Corporate Overview at the Barclays Global Healthcare Conference

REHOVOT, Israel and BRIDGEWATER, N.J., March 3, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...
26. Februar 2015 08:00 ET | Quelle: Foamix, Ltd.

Foamix to Present Corporate Overview at the Cowen & Company 35th Annual Health Care Conference

REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...
16. Dezember 2014 08:00 ET | Quelle: Foamix, Ltd.

Foamix Earns US$ 2.5 Million Milestone Payment From Bayer HealthCare

REHOVOT, Israel and BRIDGEWATER, N.J., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), a clinical-stage specialty pharmaceutical company, announces the receipt of a...
05. Dezember 2014 08:00 ET | Quelle: Foamix, Ltd.

Foamix to Present Corporate Overview at the Oppenheimer & Co. 25th Annual Healthcare Conference

REHOVOT, Israel and BRIDGEWATER, N.J., Dec. 5, 2014 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX) ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused...
14. November 2014 08:00 ET | Quelle: Foamix, Ltd.

Foamix Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2014

REHOVOT, Israel, Nov. 14, 2014 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused on developing and...
13. November 2014 08:30 ET | Quelle: Foamix, Ltd.

Foamix Announces Two New U.S. Patents Relating to Topical Tetracycline Compositions

REHOVOT, Israel and BRIDGEWATER, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX) ("Foamix Pharmaceuticals"), a clinical-stage, specialty pharmaceutical company...
10. November 2014 08:00 ET | Quelle: Foamix, Ltd.

Foamix Pharmaceuticals Third Quarter 2014 Conference Call & Webcast Scheduled for Monday, November 17, 2014

REHOVOT, Israel and BRIDGEWATER, N.J., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...

Vorherige Seite